Harry Ford
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 30
-
- Biochemical and Molecular Research 15
- DNA and Nucleic Acid Chemistry 10
- Co-authors
- Víctor E. Márquez (22 shared papers)Hiroaki Mitsuya (12 shared papers)James A. Kelley (20 shared papers)M. Arshad Siddiqui (11 shared papers)Clifford George (5 shared papers)David G. Johns (13 shared papers)Terrence R. Burke (3 shared papers)Joseph J. Barchi (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Journal of the American Chemical Society (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Biochemical and Biophysical Research Communications (3 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Harry Ford
58 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 89
- Virology 315
- Infectious Diseases 667
- Physiology 101
- Pharmaceutical Science 126
- Molecular Biology 1.1k
Countries citing papers authored by Harry Ford
This map shows the geographic impact of Harry Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Ford more than expected).
Fields of papers citing papers by Harry Ford
This network shows the impact of papers produced by Harry Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Ford. The network helps show where Harry Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 184 | |
| 2 | 1998 | 146 | |
| 3 | 1999 | 141 | |
| 4 | 1992 | 106 | |
| 5 | 1993 | 91 | |
| 6 | 1996 | 86 | |
| 7 | 1999 | 68 | |
| 8 | 1999 | 68 | |
| 9 | 1996 | 68 | |
| 10 | 2000 | 66 | |
| 11 | 1991 | 59 | |
| 12 | 1989 | 54 | |
| 13 | 1990 | 49 | |
| 14 | 2002 | 39 | |
| 15 | 1995 | 37 | |
| 16 | 1995 | 35 | |
| 17 | Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts. | 1991 | 35 |
| 18 | 1999 | 30 | |
| 19 | 1991 | 29 | |
| 20 | 1995 | 28 |
About Harry Ford
Harry Ford is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Virology and Organic Chemistry, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (30 papers), Cytomegalovirus and herpesvirus research (23 papers), Biochemical and Molecular Research (15 papers), HIV Research and Treatment (14 papers), DNA and Nucleic Acid Chemistry (10 papers), Herpesvirus Infections and Treatments (5 papers), Virus-based gene therapy research (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). The work is most often cited by research in Virology (315 citations), Infectious Diseases (667 citations), Physiology (101 citations), Pharmaceutical Science (126 citations) and Molecular Biology (1.1k citations). Harry Ford has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Víctor E. Márquez, Hiroaki Mitsuya, James A. Kelley, M. Arshad Siddiqui, Clifford George, David G. Johns, Terrence R. Burke, Joseph J. Barchi, John S. Driscoll and Mark S. Smyth. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of the American Chemical Society, Cancer Chemotherapy and Pharmacology, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.